NCT07345897 Emergency Department-based Cervical Cancer Screening Through Self-sampling
| NCT ID | NCT07345897 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | HPV |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-02-13 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-02-13 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.
Eligibility Criteria
Inclusion Criteria: * Cisgender women and transgender/non-binary individuals with a cervix, * Age 30 - 65 years, and demonstrating decisional capacity to consent to participate with no known exclusion criteria present. Exclusion Criteria: * Past hysterectomy with cervical removal * Known infection with HIV (as screening recommendations for people with HIV differ from the general population) * Inability to consent (e.g., lacking decisional capacity, intoxicated, or in distress) * Current pregnancy or in the three months after giving birth * Use of vaginal ovules, creams or washes, vaginal contraceptives or condoms within past 3 days * Sexual intercourse or transvaginal ultrasound scans or gynecological examinations within past 2 days
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07345897 clinical trial?
This trial is open to female participants only, aged 30 Years or older, up to 65 Years, studying HPV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07345897 currently recruiting?
Yes, NCT07345897 is actively recruiting participants. Contact the research team at peter_macdowell@urmc.rochester.edu for enrollment information.
Where is the NCT07345897 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07345897 clinical trial?
NCT07345897 is sponsored by University of Rochester. The trial plans to enroll 200 participants.